Change in Cardiac Geometry and Function in CKD Children During Strict BP Control
Open Access
- 1 February 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 8 (2) , 203-210
Abstract
Summary: Background and objectives: Left ventricular hypertrophy (LVH) and abnormal systolic function are present in a high proportion of children with CKD. This study evaluated changes in left ventricular (LV) geometry and systolic function in children with mild to moderate CKD as an ancillary project of the Effect of Strict Blood Pressure Control and ACE Inhibition on Progression of Chronic Renal Failure in Pediatric Patients trial. Design, setting, participants, & measurements: Echocardiograms and ambulatory BP monitoring were performed at baseline and at 1- or 2-year follow-up in 84 patients with CKD and 24-hour mean BP above the 50th percentile and/or receiving fixed high-dose angiotensin converting enzyme inhibition and randomized to conventional or intensified BP control. Results: LVH prevalence decreased from 38% to 25% (P2.7; PPP=0.05). In multivariate analysis, improvement in myocardial function was associated with reduction in BP (r=−0.4; P<0.05), independently of LVMI reduction. Conclusions: In children with CKD, angiotensin converting enzyme inhibition with improved BP control, LVH regression, and improved systolic function was observed within 12 months. Lowering BP to the low-normal range led to a slightly more marked improvement in myocardial function but not in LVMI.Keywords
This publication has 43 references indexed in Scilit:
- Age-Specific Reference Intervals for Indexed Left Ventricular Mass in ChildrenJournal of the American Society of Echocardiography, 2009
- Reduced Systolic Myocardial Function in Children with Chronic Renal InsufficiencyJournal of the American Society of Nephrology, 2007
- Regression of left ventricular hypertrophy in children with antihypertensive therapyPediatric Nephrology, 2007
- Evaluation of Concentric Left Ventricular Geometry in HumansHypertension, 2005
- Blood Pressure–Independent Attenuation of Cardiac Hypertrophy by AT 1 R-AS Gene TherapyHypertension, 2002
- Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjectsThe Journal of Pediatrics, 1997
- ACE inhibitor ramipril is more effective than the ??-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) studyJournal Of Hypertension, 1995
- Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.Hypertension, 1994
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergyThe American Journal of Cardiology, 1976